Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis

Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis

Abstract Background and aims The existing evidence has indicated that hyperthermia ablation (HA) and HA combined with transarterial chemoembolization (HATACE) are the optimal alternative to surgical resection for patients with hepatocellular carcinoma (HCC) in the COVID‐19 crisis. However, the evide...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zheng Li, Qiang Li, Xiaohu Wang, Weiqiang Chen, Xiaodong Jin, Xinguo Liu, Fei Ye, Zhongying Dai, Xiaogang Zheng, Ping Li, Chao Sun, Xiongxiong Liu, Qiuning Zhang, Hongtao Luo, Ruifeng Liu
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
COVID‐19
hepatocellular carcinoma
hyperthermia ablation
meta‐analysis
SARS‐CoV‐2
transarterial chemoembolization
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/0111e4d5fc90471880ca6ac191ad8656
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/0111e4d5fc90471880ca6ac191ad8656

Ejemplares similares